Bavarian Nordic A/S
Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an or… Read more
Bavarian Nordic A/S (BVNKF) - Total Liabilities
Latest total liabilities as of September 2025: $2.00 Billion USD
Based on the latest financial reports, Bavarian Nordic A/S (BVNKF) has total liabilities worth $2.00 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bavarian Nordic A/S - Total Liabilities Trend (2001–2024)
This chart illustrates how Bavarian Nordic A/S's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bavarian Nordic A/S Competitors by Total Liabilities
The table below lists competitors of Bavarian Nordic A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Songcheng Performance Develop
SHE:300144
|
China | CN¥1.46 Billion |
|
Aerospace Hi-Tech Holding Group Co Ltd
SHE:000901
|
China | CN¥2.71 Billion |
|
Sinbon Electronics Co Ltd
TW:3023
|
Taiwan | NT$15.50 Billion |
|
RXO Inc.
NYSE:RXO
|
USA | $1.74 Billion |
|
Shijiazhuang Shangtai Technology Co. Ltd. A
SHE:001301
|
China | CN¥4.26 Billion |
|
Companhia de Saneamento de Minas Gerais
SA:CSMG3
|
Brazil | R$9.16 Billion |
|
The Chemours Company
MX:CC
|
Mexico | MX$7.27 Billion |
|
Wuxi Nce Power Co Ltd
SHG:605111
|
China | CN¥438.07 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down Bavarian Nordic A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bavarian Nordic A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bavarian Nordic A/S (2001–2024)
The table below shows the annual total liabilities of Bavarian Nordic A/S from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $3.00 Billion | -25.32% |
| 2023-12-31 | $4.01 Billion | -23.43% |
| 2022-12-31 | $5.24 Billion | +11.17% |
| 2021-12-31 | $4.71 Billion | +21.99% |
| 2020-12-31 | $3.86 Billion | -25.41% |
| 2019-12-31 | $5.18 Billion | +488.61% |
| 2018-12-31 | $880.31 Million | +36.19% |
| 2017-12-31 | $646.37 Million | -19.85% |
| 2016-12-31 | $806.46 Million | +24.69% |
| 2015-12-31 | $646.78 Million | +1.83% |
| 2014-12-31 | $635.17 Million | +33.46% |
| 2013-12-31 | $475.92 Million | -11.79% |
| 2012-12-31 | $539.50 Million | -29.84% |
| 2011-12-31 | $768.99 Million | +17.10% |
| 2010-12-31 | $656.69 Million | +15.84% |
| 2009-12-31 | $566.89 Million | -16.53% |
| 2008-12-31 | $679.13 Million | +32.03% |
| 2007-12-31 | $514.39 Million | +95.57% |
| 2006-12-31 | $263.02 Million | -11.87% |
| 2005-12-31 | $298.46 Million | +4.10% |
| 2004-12-31 | $286.71 Million | +248.93% |
| 2003-12-31 | $82.17 Million | -32.24% |
| 2002-12-31 | $121.26 Million | +583.90% |
| 2001-12-31 | $17.73 Million | -- |